Safety and Protective Efficacy of Genetically Attenuated PfSPZ-GA1 Vaccine in Healthy Dutch Volunteers
Clinical trial NCT03163121 · COMPLETED
Trial details
- NCT number
- NCT03163121
- Sponsor
- Sanaria Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-12
- Primary completion
- 2018-10-25
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.